Please use this identifier to cite or link to this item: https://covid-19.conacyt.mx/jspui/handle/1000/743
Case of the index patient who caused tertiary transmission of coronavirus disease 2019 in Korea: The application of lopinavir/ritonavir for the treatment of COVID-19 pneumonia monitored by quantitative RT-PCR
Lim, J
Jeon, S
Shin, H
Kim, M
Seong, Y
Lee, W
Choe, K
Kang, Y
Lee, B
Park, S
Acceso Abierto
Atribución-NoComercial-SinDerivadas
Since mid-December of 2019, coronavirus disease 2019 (COVID-19) infection has been spreading from Wuhan, China. The confirmed COVID-19 patients in South Korea are those who came from or visited China. As secondary transmissions have occurred and the speed of transmission is accelerating, there are rising concerns about community infections. The 54-year old male is the third patient diagnosed with COVID-19 infection in Korea. He is a worker for a clothing business and had mild respiratory symptoms and intermittent fever in the beginning of hospitalization, and pneumonia symptoms on chest computerized tomography scan on day 6 of admission. This patient caused one case of secondary transmission and three cases of tertiary transmission. Hereby, we report the clinical findings of the index patient who was the first to cause tertiary transmission outside China. Interestingly, after lopinavir/ritonavir (Kaletra, AbbVie) was administered, β-coronavirus viral loads significantly decreased and no or little coronavirus titers were observed.
Journal of Korean Medical Science
2020
Preimpreso
https://coronavirus.1science.com/item/d68db485251bc2df0e85ab641e0e832c017de812
Inglés
VIRUS RESPIRATORIOS
Appears in Collections:Artículos científicos

Upload archives


File SizeFormat 
101801.pdf3.42 MBAdobe PDFView/Open